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Background: The nutritional status of patients on maintenance hemodialysis (MHD) is a strong predictor of their
survival. We assessed the reliability of a protein-energy wasting (PEW) score as a predictor of the survival of
Japanese MHD patients.
Methods: The study subjects were 254 MHD patients. PEW score was from 0 (worst; group 1) to 4 (best; group 4)
and was derived from four body nutrition compartments: serum albumin, body mass index, a normalized serum
creatinine value, and protein intake. The main outcome was all-cause mortality.
Results: A total of 26 patients died during the follow-up period of 36 months. The Kaplan-Meier analysis revealed
that the group whose score was 0–1 had a significant lower survival rate than the groups with higher (2–4) PEW
scores (P < 0.0001). In multivariate analysis, hazard ratios (HRs) were 0.214 (confidence interval (CI) 0.068–0.610,
P < 0.005) between group 1 and group 4, 0.176 (0.054–0.510, P < 0.005) between group 2 and group 4, and 0.249
(CI 0.054–0.857) between group 3 and group 4.
Conclusions: A new simple PEW score predicts the survival of MHD patients and may help to better identify
subgroups of MHD patients with a high mortality rate.
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The mortality rate of maintenance hemodialysis (MHD)
patients is still higher than the mortality rate of overall
general population of Japan as a whole [1]. Since protein-
energy wasting (PEW) is a strong predictors of MHD
patient mortality [2–4], evaluation of their nutritional
status is essential to optimally manage MHD patients.
Many different mechanisms, including muscle wasting,
abnormalities of gastrointestinal, hematopoietic, and im-
mune systems, and abnormal activation of the inflamma-
tory process, have been reported to explain the link
between PEW and mortality in HD patients [5, 6]. Clin-
ical assessment of the nutritional status of MHD patients
is mandatory, but since there is no single gold-standard
marker, easily measured in a reproducible manner that is* Correspondence: knitta@kc.twmu.ac.jp
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(http://creativecommons.org/publicdomain/zeunaffected by confounding conditions [7], MHD patients
must be screened for PEW by various measures on a
regular clinical practice [8, 9].
The aim of this study was to evaluate a simple PEW
score, based on various clinical and biological values, as
a predictor for mortality of MHD patients.Methods
Subjects and protocol
This was a retrospective cohort study conducted at a
single center in Japan. The subjects were recruited from
among patients who had been routinely dialyzed via an
arteriovenous fistula in the dialysis unit of the Shinjuku
Ishikawa Clinic for at least 6 months by the procedure
[10]. The Institutional Review Board of the Shinjuku
Ishikawa Clinic approved all study protocols (I-02-2015),
and they were performed in accordance with the Declar-
ation of Helsinki guidelines regarding ethical principlesicle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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consent was obtained from every subject.
MHD patients with malignancy, active inflammation,
liver cirrhosis, gastrointestinal bleeding, or severe illness
were excluded from participation as subjects. The patients
who were enrolled as subjects (n = 254) had been under-
going stable regular HD with a bicarbonate dialysate. The
underlying disease was chronic glomerulonephritis in 95
cases, diabetic nephropathy in 74 cases, hypertensive
nephrosclerosis in 52 cases, polycystic kidney disease in
18 cases, chronic pyeonephritis in 9 cases, and in 6 cases,
the underlying disease was unknown.
All patients were on thrice-weekly HD therapy. Blood
pressure (BP) was measured with a mercury sphygmo-
manometer with the patient in the supine position after
resting for 10 to 15 min, and mean values for the 1-
month period preceding enrollment were used in the
statistical analysis. Dry weight was targeted to achieve a
normotensive edema-free state. Information regarding
previous cardiovascular disease and smoking status was
collected from the patient’s medical records. Diabetes
was defined as a presence of diabetes and/or a fasting
plasma glucose concentration >126 mg/dl or HbA1c
value >6.5 % or prescription of glucose-lowering agent.
Laboratory and nutritional parameters
Blood was sampled before dialysis session after an over-
night fast. Serum urea nitrogen, creatinine, albumin, and
C-reactive protein (CRP) levels were measured with an
autoanalyzer (Hitachi Co., Tokyo, Japan) by standard
laboratory methods. Body mass index (BMI) was calcu-
lated by dividing body weight in kilograms by the square
of their height in meters and was expressed in kilogram
per square meter. Urea kinetics were assessed by meas-
uring a blood-based dialysis parameter, Kt/V [11], and
the mean value of the three measurements during each
of the 3 months before the start of the study was used in
the analysis.
We defined the PEW score as the grading of 1 selected
item in each of the four categories as previously reported
[12]: (1) serum albumin, (2) BMI, (3) predialysis serum
creatinine normalized by body surface area (SCr/BSA),
and (4) normalized protein catabolic rate (nPCR). The
threshold values are shown in Table 1 and are serum al-
bumin, 3.8 g/dL; BMI, 23 kg/m2; SCr/BSA, 520 mmol/L/
m2; and nPNA, 0.8 g/kg/day. The nPCR was used as anTable 1 Definition of protein-energy wasting score
Serum albumin (g/dL) >3.8
Body mass index (kg/m2) >23
SCr/BSA (μmol/L/m2) >520
nPCR (g/kg/day) >0.8
Scr/BSA predialysis serum creatinine/body surface area, nPCR normalized
protein catabolic rateindirect indicator of protein intake and was calculated by
using the formula previously reported [13]. BSA was esti-
mated by the Du Bois formula [14]. The 540 mmol/L/m2
threshold value for the SCr/BSA variable was selected
based on the results of a receiver operating characteristics
(ROC) curve analysis (Fig. 1).
Study outcome
Data for endpoints were obtained from hospital charts.
The primary endpoint of the study was all-cause mor-
tality during the follow-up period from January 1, 2011
to December 31, 2014. The vital status of the subjects
was determined by searching the electronic dialysis
records. Patients were censored if they were alive on
December 31, 2014.
Statistical analysis
Normally distributed, unpaired continuous values were
expressed as means ± SD and compared by performing an
analysis of variance. Nonparametric values were expressed
as median values and compared by performing the
Kruskal-Wallis test. Categorical values were expressed as
percentages and compared by performing the Fisher’s
exact test. We considered some variables whose P value
was <0.10 according to the results of the univariate logistic
regression analyses, in addition to gender, presence of
diabetes and history of myocardial infarction, peripheral
vascular disease and stroke, CRP, and Kt/V.
The survival analysis was based on the Kaplan-Meier
curve with subjects censored for death. A log-rank test
was used to compare the survival rates of two groups.
A multivariate Cox proportional hazard model with ad-
justment for multivariate factors was used to evaluate
mortality risk. Results were expressed as a hazard ratio
(HR) with 95 % confidence interval (CI). A P value
<0.05 was considered to be statistically significant. All
statistical analyses were performed by using the SAS
version 9.2 software program (SAS Institute Inc., Cary,
NC, USA) for Windows personal computers.
Results
The baseline characteristics of the study cohort accord-
ing to PEW score are shown in Table 2. The study
cohort consisted of 70 females and 184 males. The mean
age of the 254 subjects was 59.3 ± 12.8 years, and their
mean dialysis vintage was 11.0 ± 7.7 years. Their mean
BMI was 22.3 ± 3.7 kg/m2. All of the subjects had an ar-
teriovenous fistula. None of the subjects had residual
renal function (urine volume ≥100 mL/day). Diabetes
was present in 31.1 %. History of stroke, myocardial in-
farction or peripheral vascular disease was present in
17.7, 7.1, and 4.7, respectively. The mean dialysis dose
was 1.45 as a single pool Kt/V, and mean protein intake
was 0.93 g/kg/day. The moderate and severe wasting
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Fig. 1 Receiver operating characteristic (ROC) curve analysis to determine the optimal cut-off value of serum creatinine/body surface area (Scr/BSA) for
detecting mortality rate
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cohort.
During the follow-up period of 36-months, a total of 26
patients died, and a cardiovascular death occurred in 8 pa-
tients. The Kaplan-Meier analysis revealed that the group
with a PEW score of 0–1 (S1) (n = 36) had a significant
lower survival rate than the groups with higher (2–4)
PEW scores (S2, S3, S4) (P < 0.0001, Fig. 2). Table 3 showsTable 2 Baseline characteristics of the study subjects according to t
Scores 0–1
Clinical and laboratory parameters All Severe wasting
Number of patients 254 36
Number of deaths 26 11
Age (years) 59.3 ± 12.8 66.2 ± 11.5**
Male (%) 72.8 % 75.0 %
Dry weight (kg) 60.2 ± 13.5 56.2 ± 9.6**
BSA (m2) 1.65 ± 0.20 1.59 ± 0.17**
Dialysis vintage (years) 11.0 ± 7.7 8.8 ± 7.7
C-reactive protein (mg/dL) 0.29 ± 0.41 0.31 ± 0.29
Serum albumin (g/dL) 3.88 ± 0.32 3.60 ± 0.28**
SCr (μmol/L) 1050 ± 217 808 ± 185**
SCr/BSA (μmol/L/m2) 641 ± 121 507 ± 101**
Kt/V 1.45 ± 0.24 1.39 ± 0.23
nPCR (g protein/kg/day) 0.93 ± 0.17 0.78 ± 0.14**
BSA body surface area, Scr serum creatinine, Kt/V single pool urea kinetics, nPCR no
*P < 0.001 versus score 4; **P < 0.05 versus score 4the survival predictive factors in MHD patients. History of
peripheral vascular disease was only survival predictive
factor (P < 0.005).
The HR was 0.239 (CI 0.088–0.607, P < 0.005) between
the severe wasting group (score 0–1; group 1) and the
normal nutritional status group (score 4; group 4), 0.131
(0.041–0.361, P < 0.001) between the moderate wasting
group (score 2; group 2) and the normal nutritionalhe PEW score
Score 2 Score 3 Score 4
Moderate wasting Slight wasting Normal nutritional status
82 97 39
7 5 3
63.1 ± 11.8** 55.9 ± 12.6 53.6 ± 11.3
69.5 % 70.1 % 84.6 %
56.8 ± 14.0** 60.4 ± 13.2** 70.7 ± 10.2
1.59 ± 0.21** 1.65 ± 0.20** 1.78 ± 0.16
11.0 ± 6.9 12.0 ± 8.1 10.3 ± 7.8
0.31 ± 0.43 0.26 ± 0.31 0.33 ± 0.63
3.76 ± 0.29** 3.98 ± 0.27** 4.13 ± 0.19
999 ± 178** 1120 ± 173* 1208 ± 200
632 ± 110* 684 ± 108 678 ± 99
1.47 ± 0.24* 1.49 ± 0.24* 1.38 ± 0.19
0.88 ± 0.16** 1.00 ± 0.16 1.01 ± 0.13
rmalized protein catabolic rate
Fig. 2 Kaplan-Meier curve survival analysis according to protein-energy wasting (PEW) score. S1 (score of 0 or 1) had severe wasting, S2 (score of 2)
had moderate wasting, S3 (score of 3) had slight wasting, and S4 (score of 4) had a normal nutritional status
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tween slight wasting group (score 3; group 3) and the
normal nutritional status group (score 4; group 4) (data
not shown). In multivariate analysis, HRs were respect-
ively 0.214 (CI 0.068–0.610, P < 0.005) between group 1
and group 4, 0.176 (0.054–0.510, P < 0.005) between
group 2 and group 4, and 0.249 (CI 0.054–0.857) be-
tween group 3 and group 4 (Table 3).Discussion
We evaluated a simple PEW score based on simple avail-
able clinical parameters and demonstrated that it can pre-
dict survival of MHD patients. Although an abnormal
nutritional status is frequently reported in MHD patients,
there is no single nutrition parameter that can predict
PEW [15–17]. We hope to take advantage of a simple nu-
tritional marker to make recommendations and improve
the outcomes of MHD patients.Table 3 Survival predictive factors by Cox proportional hazard
models
Patients characteristics and PEW score HR CI min CI max P value
Gender (male/female) 1.313 0.437 4.970
Diabetes 0.676 0.231 1.761
Myocardial infarction 0.920 0.208 3.321
Peripheral vascular disease 8.762 2.522 27.134 <0.005
Stroke 0.995 0.308 2.639
C-reactive protein 1.009 0.570 1.102
KT/V 0.176 0.019 1.766
Score 2 versus 0–1 0.214 0.068 0.610 <0.005
Score 3 versus 0–1 0.176 0.054 0.510 <0.005
Score 4 versus 0–1 0.249 0.054 0.857 <0.05
HR hazard ratio, CI confidence interval, Kt/V single pool urea kineticsHypoalbuminemia is a strong predictor of mortality
in MHD patients. Kalantar-Zadeh et al. [18] showed
that a serum albumin levels <3.8 g/dL in MHD patients
were correlated with increased cardiovascular deaths
independent of demographic, clinical, or laboratory
characteristics, and Malfra et al. [19] demonstrated that
a serum albumin level <3.7 g/dL was a strong predictor
for mortality of dialysis patients. A 10-year cohort study
reported an increased risk of death in HD patients with
serum albumin level below 3.8 g/dL [20]. However,
Friedman and Fadem [21] have recently shown that
serum albumin levels should be used cautiously as a
nutritional marker in patients with chronic kidney dis-
ease (CKD) because low serum albumin levels in HD
patients are known to be associated with both malnu-
trition and inflammation.
A lower prevalence of inflammation has been re-
ported in dialysis patients in Asian countries, including
Japan and Korea, and the lower prevalence may depend
on genetic factors and cultural habits, including diet in-
take [22, 23]. Baseline obesity in MHD patients appears
to be paradoxically associated with a higher survival
rate [24, 25]. Asian-Americans have been reported to
have a much lower adjusted relative mortality rate than
Caucasian dialysis patients, but Asian-Americans have
a significantly lower BMI [26]. The International Society
of Renal Nutrition and Metabolism (ISRNM) proposed a
BMI of less than 23 as a diagnostic criterion for PEW in
patients with chronic kidney disease (CKD), but they have
not expanded their recommendation to South Asian CKD
patients [27].
nPCR is associated with dietary protein intake [28],
and nPCR has been reported to be an independent pre-
dictor of mortality in MHD patients [29]. A study by
Chandna et al. showed a substantial drop in the nPCR in
CKD patients in the 3 months preceding the start of
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recommended a daily protein intake of 1.2–1.3 g/kg/day
for MHD patients and contributed to the low nPCR
levels [31]. Lukowsky et al. found that a decrease in
nPCR of over 0.2 g/kg/day within a 3-month period was
associated with increased risk of death [4].
Because no single parameter provides a comprehen-
sive and conclusive assessment of nutritional status, a
collective evaluation of multiple nutritional markers is
recommended by K/DOQI guidelines [32]. A recent
panel of experts suggested using markers from four differ-
ent categories (biochemistry, body mass, muscle mass,
and dietary intake) for the clinical diagnosis of PEW [27].
Three out of those four categories should be selected but
at least one biochemical indicator must be included. How-
ever, to the best our knowledge, their combination has not
yet been tested for assessing nutritional status in HD
patients.
Moreau et al. [12] developed a simple PEW score in-
cluding one parameter from each major group generally
identified to interfere in nutritional status: (1) biological
parameters, (2) body composition, (3) muscle mass, and
(4) nutrient intake. It seems important to add laboratory
information, such as serum levels of albumin and Cr to
other clinical information, such as BMI [19]. Since muscle
mass, which is the major part of the body strongly associ-
ated with survival, is difficult to assess, they chose to use
predialysis Scr values normalized by BSA. The Scr/BSA
reflects the difference in Western and Asian and may
differ by Cr intake and metabolism. This may be the rea-
son why Cr is not used routinely. Indeed, SCr/BSA gave a
better fit in the Cox model than raw Scr [12]. Finally, they
added information on nutrient intake by entering in the
score the protein intake as estimated by normalized pro-
tein nitrogen appearance (nPNA also called nPCR). This
value belongs to all current international recommenda-
tions and can be calculated easily by using dialysis gener-
ator software. Added to the model, it improved survival
prediction over albumin alone.
It should be noted that the score by itself was not better
than the four parameters added into the model as separate
variables [12]. That was not unexpected because informa-
tion given by the score is already brought by all variables
included into the score. However, we believe that this is
the interest of this score to encourage the dialysis staff to
pay attention to all these variables taken together. The
PEW score could be obtained within minutes at bedside,
with no additional equipment, at no expense and therefore
be added to the arsenal of patient’s general record and
follow-up. The final patient classification we obtained
corresponds well to the published literature on the preva-
lence of nutritional disorders in dialysis patients: 37 % of
patients present with moderate and 19 % with severe
impairment in their nutritional status [33].Conclusions
The routine use of the simple nutritional score may help
to identify PEW in MHD patients. Further studies may be
needed to verify the robustness of the PEW score in Asian
populations because of the differences in body compos-
ition and clinical practice.
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